Plexus 과거 순이익 실적
과거 기준 점검 5/6
Plexus은 연평균 3.6%의 비율로 수입이 증가해 온 반면, Electronic 산업은 수입이 3.8% 증가했습니다. 매출은 연평균 4%의 비율로 증가했습니다. Plexus의 자기자본이익률은 12.6%이고 순이익률은 4.4%입니다.
핵심 정보
3.58%
순이익 성장률
5.01%
주당순이익(EPS) 성장률
| Electronic 산업 성장률 | 15.34% |
| 매출 성장률 | 3.96% |
| 자기자본이익률 | 12.59% |
| 순이익률 | 4.35% |
| 최근 순이익 업데이트 | 04 Apr 2026 |
최근 과거 실적 업데이트
Recent updates
새로운 내러티브 • May 04
Semicap And Aerospace Slowdowns Will Pressure Margins And Constrain Future Cash Generation
Catalysts About Plexus Plexus provides design, engineering and manufacturing services for complex electronic products across aerospace and defense, healthcare, industrial and other end markets. What are the underlying business or industry changes driving this perspective?
내러티브 업데이트 • Apr 25
PLXS: Higher P/E And Rich Multiple Will Likely Cap Future Upside
Plexus' analyst fair value estimate has been adjusted from $200.80 to $210.80 as analysts factor in updated assumptions on growth, margins and future P/E, supported by a series of recent target increases and an upgrade from major research firms. Analyst Commentary Recent Street research on Plexus focuses on refreshed targets and an upgrade, which analysts link to their updated assumptions on growth, margins and the P/E they are willing to apply to the stock.내러티브 업데이트 • Apr 10
PLXS: Higher P/E Assumptions Will Likely Limit Upside Despite Buybacks
Analysts have raised their price targets on Plexus from $25 to $50, citing updated assumptions around discount rates and future P/E ratios that support a refined view of the stock's valuation. Analyst Commentary Recent research updates on Plexus focus heavily on how revised discount rates and updated P/E assumptions shape the new price targets.내러티브 업데이트 • Mar 27
PLXS: Raised Price Views And Buybacks Will Likely Support Balanced Trading Outlook
Analysts have raised their Plexus price targets by $25 to $50, pointing to modestly adjusted assumptions for growth, margins, and future P/E to support their higher valuation views. Analyst Commentary Recent research points to a cluster of higher Plexus price targets in the US$25 to US$50 range above prior levels, reflecting tweaked assumptions around growth, margins, and the P/E multiple investors might be willing to pay.내러티브 업데이트 • Mar 12
PLXS: Updated Earnings Views And Buybacks Will Likely Support Balanced Trading Outlook
Analysts have raised their average Plexus price target by a combined $105. This reflects updated assumptions on discount rates, revenue growth, profit margins and future P/E multiples.내러티브 업데이트 • Feb 26
PLXS: Higher Earnings Assumptions And Buybacks May Sustain Sideways Trading
Narrative Update on Plexus The analysts’ average price target for Plexus has increased by a combined $105 in recent reports, reflecting updated assumptions for discount rates, revenue growth, profit margins, and a slightly lower future P/E multiple. Analyst Commentary Recent Street research on Plexus centers on higher price targets, with analysts updating their models around discount rates, revenue expectations, margin assumptions, and a slightly lower future P/E multiple.내러티브 업데이트 • Feb 09
PLXS: Higher Earnings Assumptions May Support Sideways Trading Near Current Range
The analyst price target for Plexus has shifted from US$159 to about US$201, as analysts factor in updated views on revenue growth, profit margins, and the P/E multiple they are comfortable assigning to the stock. Analyst Commentary Bullish analysts have increased their price targets in several steps, including US$25, US$30, and US$50 adjustments, which lines up with the higher overall target of about US$201.
새로운 내러티브 • Jan 31
Aerospace And Defense Outsourcing Wave Will Support Stronger Long Term Outlook
Catalysts About Plexus Plexus provides outsourced design, engineering and manufacturing solutions for complex products across Healthcare, Industrial and Aerospace and Defense end markets. What are the underlying business or industry changes driving this perspective?내러티브 업데이트 • Jan 26
PLXS: Manufacturing Partnership And Stable Outlook Will Likely Support Sideways Trading
Analysts have maintained their Plexus fair value estimate at $159.00. The updated assumptions reflect slightly adjusted revenue growth, revised profit margin expectations, and a marginally higher future P/E multiple as they refine their price target framework.내러티브 업데이트 • Jan 12
PLXS: Robust Finish And New Partnership Will Likely Support Sideways Trading
Analysts have raised their Plexus price target to $150 from $140, citing solid recent results and consistent execution. They also noted a more cautious stance on longer term estimates given the current macro backdrop.분석 기사 • Dec 30
Is It Too Late To Consider Buying Plexus Corp. (NASDAQ:PLXS)?
Plexus Corp. ( NASDAQ:PLXS ), is not the largest company out there, but it saw a double-digit share price rise of over...내러티브 업데이트 • Dec 24
PLXS: Shares Will Likely Trade Sideways As Robust Finish Meets Rich Pricing
Analysts have nudged their Plexus price target higher to $150 from $140, citing a robust fiscal year finish that beat sales and earnings expectations while still acknowledging valuation and macroeconomic uncertainties. Analyst Commentary Street research on Plexus reflects a mix of optimism around recent execution and caution regarding valuation and the macro backdrop, leading to a more balanced risk reward profile at current levels.내러티브 업데이트 • Dec 10
PLXS: Shares Will Likely Trade Steadily As Execution Offsets Macro Caution
Analysts have modestly increased their Plexus price target to approximately $159 per share. This reflects confidence in the company’s robust execution and long term growth prospects, despite a more cautious stance on the macro environment and valuation.내러티브 업데이트 • Nov 26
PLXS: Shares Will Likely Climb With Confidence In Earnings Momentum
Analysts have modestly increased Plexus’s average price target, citing robust recent results, a positive management outlook, and continued confidence in the company’s growth prospects, with new targets ranging up to $165 from previous levels around $140 to $160. Analyst Commentary Following the latest quarterly report, analysts have provided updated perspectives on Plexus, balancing improved outlooks with some caution regarding future risks.내러티브 업데이트 • Nov 09
PLXS: Shares Will Likely Reflect Mixed Views As Macro Uncertainty Persists
Analysts have slightly raised their price targets for Plexus, citing strong recent results and ongoing confidence in the company's growth prospects. The new targets range from $150 to $165, which is an increase of $10 to $5 from previous estimates.내러티브 업데이트 • Oct 26
Execution On Expansion Plans Will Shape Near-Term Manufacturing Opportunities
The analyst consensus price target for Plexus has increased by $4.40 to $159.00. This reflects upward revisions in revenue growth expectations and ongoing confidence in management’s execution, even as some firms have issued cautious outlooks recently.Seeking Alpha • Sep 11
Plexus: Pipeline Underscores The Growth Potential Amid Short-Term Headwinds
Summary Plexus delivers steady execution and stable margins, but faces uneven growth and slower program ramps compared to AI-focused peers. Revenue and earnings growth are projected to be modest, with recovery in industrial and healthcare end markets critical for upside. Valuation remains reasonable, trading near historical P/E, but lacks catalysts to drive a bullish re-rating in the near term. With limited near-term upside and risks from slow program execution, I maintain a neutral stance on Plexus shares. Read the full article on Seeking Alpha분석 기사 • Sep 11
Return Trends At Plexus (NASDAQ:PLXS) Aren't Appealing
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly...분석 기사 • Jun 24
Why Investors Shouldn't Be Surprised By Plexus Corp.'s (NASDAQ:PLXS) P/E
Plexus Corp.'s ( NASDAQ:PLXS ) price-to-earnings (or "P/E") ratio of 25.4x might make it look like a sell right now...Seeking Alpha • Sep 16
Plexus Is Overvalued Despite Its Unique Position In Manufacturing
Summary Plexus has a distinct position in the manufacturing market for low-to-mid volume in specialized industries with high regulatory requirements, like healthcare and defense. This provides somewhat of a moat. Despite this strength, the stock is currently overvalued based on my peer and company-specific historical valuation analysis. I expect its P/E non-GAAP ratio will contract. In an optimistic scenario, there is the potential for a 12-month return of 20%+. However, this depends on EPS up revisions continuing and a moderate contraction in its P/E ratio. Even in the event of a strong 12-month return, the long-term thesis is weaker due to lower fundamental growth estimates for FY26 against FY25. Read the full article on Seeking Alpha
새로운 내러티브 • Sep 04
Aerospace And Healthcare Drive Growth Amid Rising Efficiency And Responsible Practices
Expected revenue growth driven by strong demand in Aerospace, Healthcare/Life Sciences, and semiconductor sectors, enhancing future earnings.매출 및 비용 세부 내역
매출 및 비용 세부 내역
Plexus가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.
순이익 및 매출 추이
| 날짜 | 매출 | 순이익 | 일반관리비 | 연구개발비 |
|---|---|---|---|---|
| 04 Apr 26 | 4,310 | 188 | 211 | 0 |
| 03 Jan 26 | 4,127 | 177 | 202 | 0 |
| 27 Sep 25 | 4,033 | 173 | 200 | 0 |
| 28 Jun 25 | 4,025 | 163 | 202 | 0 |
| 29 Mar 25 | 3,968 | 143 | 202 | 0 |
| 28 Dec 24 | 3,954 | 120 | 197 | 0 |
| 28 Sep 24 | 3,961 | 112 | 190 | 0 |
| 29 Jun 24 | 3,934 | 111 | 180 | 0 |
| 30 Mar 24 | 3,995 | 102 | 173 | 0 |
| 30 Dec 23 | 4,099 | 126 | 175 | 0 |
| 30 Sep 23 | 4,210 | 139 | 176 | 0 |
| 01 Jul 23 | 4,310 | 149 | 177 | 0 |
| 01 Apr 23 | 4,270 | 171 | 179 | 0 |
| 31 Dec 22 | 4,088 | 157 | 173 | 0 |
| 01 Oct 22 | 3,811 | 138 | 167 | 0 |
| 02 Jul 22 | 3,531 | 121 | 159 | 0 |
| 02 Apr 22 | 3,364 | 111 | 151 | 0 |
| 01 Jan 22 | 3,356 | 126 | 149 | 0 |
| 02 Oct 21 | 3,369 | 139 | 144 | 0 |
| 03 Jul 21 | 3,439 | 143 | 146 | 0 |
| 03 Apr 21 | 3,482 | 152 | 147 | 0 |
| 02 Jan 21 | 3,368 | 123 | 146 | 0 |
| 03 Oct 20 | 3,390 | 117 | 153 | 0 |
| 04 Jul 20 | 3,287 | 117 | 153 | 0 |
| 04 Apr 20 | 3,230 | 106 | 153 | 0 |
| 04 Jan 20 | 3,251 | 117 | 152 | 0 |
| 28 Sep 19 | 3,164 | 109 | 148 | 0 |
| 29 Jun 19 | 3,125 | 145 | 146 | 0 |
| 30 Mar 19 | 3,052 | 146 | 144 | 0 |
| 29 Dec 18 | 2,962 | 134 | 143 | 0 |
| 29 Sep 18 | 2,874 | 13 | 140 | 0 |
| 30 Jun 18 | 2,772 | -31 | 133 | 0 |
| 31 Mar 18 | 2,665 | -32 | 130 | 0 |
| 30 Dec 17 | 2,570 | -15 | 125 | 0 |
| 30 Sep 17 | 2,528 | 112 | 126 | 0 |
| 01 Jul 17 | 2,511 | 102 | 124 | 0 |
| 01 Apr 17 | 2,560 | 103 | 122 | 0 |
| 31 Dec 16 | 2,574 | 90 | 119 | 0 |
| 01 Oct 16 | 2,556 | 76 | 115 | 0 |
| 02 Jul 16 | 2,572 | 81 | 115 | 0 |
| 02 Apr 16 | 2,574 | 79 | 116 | 0 |
| 02 Jan 16 | 2,606 | 86 | 118 | 0 |
| 03 Oct 15 | 2,654 | 94 | 122 | 0 |
| 04 Jul 15 | 2,652 | 97 | 122 | 0 |
양질의 수익: PLXS는 고품질 수익을 보유하고 있습니다.
이익 마진 증가: PLXS의 현재 순 이익률 (4.4%)은 지난해 (3.6%)보다 높습니다.
잉여현금흐름 대비 순이익 분석
과거 순이익 성장 분석
수익추이: PLXS의 수익은 지난 5년 동안 연평균 3.6% 증가했습니다.
성장 가속화: 지난 1년간 PLXS 의 수익 증가율(30.2%)은 연간 평균(3.6%)을 초과합니다.
수익 대 산업: PLXS의 지난 1년 수익 증가율(30.2%)은 Electronic 업계의 13.4%를 상회했습니다.
자기자본이익률
높은 ROE: PLXS의 자본 수익률(12.6%)은 낮음으로 평가됩니다.
총자산이익률
투하자본수익률
우수한 과거 실적 기업을 찾아보세요
기업 분석 및 재무 데이터 상태
| 데이터 | 최종 업데이트 (UTC 시간) |
|---|---|
| 기업 분석 | 2026/05/28 23:36 |
| 종가 | 2026/05/28 00:00 |
| 수익 | 2026/04/04 |
| 연간 수익 | 2025/09/27 |
데이터 소스
당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.
| 패키지 | 데이터 | 기간 | 미국 소스 예시 * |
|---|---|---|---|
| 기업 재무제표 | 10년 |
| |
| 분석가 컨센서스 추정치 | +3년 |
|
|
| 시장 가격 | 30년 |
| |
| 지분 구조 | 10년 |
| |
| 경영진 | 10년 |
| |
| 주요 개발 | 10년 |
|
* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.
별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.
분석 모델 및 스노우플레이크
이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.
Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.
산업 및 섹터 지표
산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.
분석가 소스
Plexus Corp.는 15명의 분석가가 다루고 있습니다. 이 중 5명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
| 분석가 | 기관 |
|---|---|
| Reik Read | Baird |
| Wamsi Mohan | BofA Global Research |
| Andrew Huang | B. Riley Securities, Inc. |